Zev Sthoeger

Summary

Publications

  1. ncbi request reprint [AIDS - an old disease with new challenges]
    Zev Sthoeger
    Clinical Immunology, Allergy and AIDS Center, Kaplan Medical Center, Rehovot, Israel, affiliated to the Hadassah Medical School, Jerusalem, Israel
    Harefuah 152:194-5, 249. 2013
  2. pmc The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus
    Zev Sthoeger
    Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
    PLoS ONE 8:e60394. 2013
  3. ncbi request reprint [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers]
    Daniel Elbirt
    Internal Medicine B and the Altergy, Clinical Immunology and AIDS Unit, Kaplan Medical Center, Rehovot affiliated to the Medical School, Hebrew University, Hadassah, Jerusalem
    Harefuah 152:224-9, 246. 2013
  4. ncbi request reprint [Hypersensitivity reaction to radio contrast media: diagnosis, prevention and treatment]
    Keren Mahlab-Guri
    Department of Medicine B, Clinical Immunology, Allergy and AIDS Center, Kaplan Medical Center Rehovot, Israel affiliated to the Hebrew University Hadassah Medical School, Jerusalem, Israel
    Harefuah 151:412-5, 435. 2012
  5. doi request reprint Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir
    Keren Mahlab-Guri
    Clinical Immunology, Allergy and AIDS, Kaplan Medical Center, Rehovot, Israel
    J Asthma 48:860-3. 2011
  6. ncbi request reprint [Recurrent infections in an ITP patient treated with rituximab]
    Shira Rosenberg-Bezalel
    Department of Medicine B, Clinical Immunology Allergy and AIDS Center, Kaplan Medical Center, Rehovot, srael
    Harefuah 151:617-9, 655. 2012
  7. ncbi request reprint Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras
    Zev Sthoeger
    Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel
    J Clin Immunol 23:91-9. 2003
  8. ncbi request reprint Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis
    Molly Dayan
    Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
    Hum Immunol 65:571-7. 2004
  9. ncbi request reprint [New usage for an old drug: acetylcysteine for contrast-induced nephropathy]
    Ilan Asher
    Internal Medicine B Department, Kaplan Medical Center, Rehovot, Israel
    Harefuah 144:642-6; 675. 2005

Collaborators

  • Ilan Asher
  • Edna Mozes
  • Itzhak Levy
  • Keren Mahlab-Guri
  • Daniel Elbirt
  • Shira Rosenberg-Bezalel
  • Sara Radian-Sade
  • Molly Dayan
  • Shira Rosenberg-Bezalet
  • Slava Litachevsky
  • Keren Mahlev-Guri
  • Pearl Herskovitz
  • Amnon Zung
  • Serge Gradstein
  • Michael Sela
  • Jacob Abarbanel
  • Alex Neiman

Detail Information

Publications9

  1. ncbi request reprint [AIDS - an old disease with new challenges]
    Zev Sthoeger
    Clinical Immunology, Allergy and AIDS Center, Kaplan Medical Center, Rehovot, Israel, affiliated to the Hadassah Medical School, Jerusalem, Israel
    Harefuah 152:194-5, 249. 2013
    ..Caring for HIV-infected patients with other chronic diseases is challenging and requires a muLtidisciplinary approach. ...
  2. pmc The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus
    Zev Sthoeger
    Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
    PLoS ONE 8:e60394. 2013
    ..The present studies demonstrate that hCDR1 is also capable of down-regulating significantly (and specifically to lupus) IFN-α gene expression. Thus, hCDR1 has a potential role as a novel, disease specific treatment for lupus...
  3. ncbi request reprint [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers]
    Daniel Elbirt
    Internal Medicine B and the Altergy, Clinical Immunology and AIDS Unit, Kaplan Medical Center, Rehovot affiliated to the Medical School, Hebrew University, Hadassah, Jerusalem
    Harefuah 152:224-9, 246. 2013
    ..In this study, we summarize the cases from the AIDS center in the Kaplan Medical Center and the Sheba Medical Center after possible exposure to HIV (occupational or sexual)...
  4. ncbi request reprint [Hypersensitivity reaction to radio contrast media: diagnosis, prevention and treatment]
    Keren Mahlab-Guri
    Department of Medicine B, Clinical Immunology, Allergy and AIDS Center, Kaplan Medical Center Rehovot, Israel affiliated to the Hebrew University Hadassah Medical School, Jerusalem, Israel
    Harefuah 151:412-5, 435. 2012
    ..Prophylactic treatment before its administration may prevent hypersensitivity reactions to radio contrast media...
  5. doi request reprint Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir
    Keren Mahlab-Guri
    Clinical Immunology, Allergy and AIDS, Kaplan Medical Center, Rehovot, Israel
    J Asthma 48:860-3. 2011
    ..This may cause Cushing's syndrome (laboratory and clinical) with adrenal suppression...
  6. ncbi request reprint [Recurrent infections in an ITP patient treated with rituximab]
    Shira Rosenberg-Bezalel
    Department of Medicine B, Clinical Immunology Allergy and AIDS Center, Kaplan Medical Center, Rehovot, srael
    Harefuah 151:617-9, 655. 2012
    ..The main possibilities that this patient presents include aggravation of CVID, first presented as ITP, after Rituximab treatment versus CVID secondary to Rituximab treatment...
  7. ncbi request reprint Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras
    Zev Sthoeger
    Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel
    J Clin Immunol 23:91-9. 2003
    ..Thus, SLE serology and glomerular pathology were reproducibly demonstrated in two models of human SLE. These models should allow the evaluation of potential therapies for the treatment of lupus patients...
  8. ncbi request reprint Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis
    Molly Dayan
    Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
    Hum Immunol 65:571-7. 2004
    ....
  9. ncbi request reprint [New usage for an old drug: acetylcysteine for contrast-induced nephropathy]
    Ilan Asher
    Internal Medicine B Department, Kaplan Medical Center, Rehovot, Israel
    Harefuah 144:642-6; 675. 2005
    ..N-acetylcysteine has a safety profile and low cost. Taken together, N-acetylcysteine is recommended for the prevention of contrast-induced nephropathy in high-risk patients...